Association between birth weight in preterm neonates and the BclI polymorphism of the glucocorticoid receptor gene

Journal of Steroid Biochemistry and Molecular Biology

Volumn 111, Issue 1-2, 2008, Pages 91-94

  Bertalan, Rita ^a   Patocs, Attila ^a   Vasarhelyi, Barna ^b   Treszl, Andras ^b   Varga, Ibolya ^a   Szabo, Eva ^c   Tamas, Judit ^c   Toke, Judit ^a   Boyle, Belema ^a   Nobilis, Andras ^a   Rigo Jr , Janos ^a   Racz, Karoly ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Csolnoky Ferenc County Hospital   (Hungary)

Author keywords

BclI polymorphism; Birth weight; Glucocorticoid receptor gene; Maternal dexamethasone treatment; Perinatal morbidity; Preterm neonates

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PERINATAL MORBIDITY; PREMATURITY; PREVALENCE; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

BIRTH WEIGHT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH; RECEPTORS, GLUCOCORTICOID;

EID: 48049083534     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.05.002     Document Type: Article

References (41)

1. Watterberg K.L. Adrenocortical function and dysfunction in the fetus and neonate. Semin. Neonatol. 9 1 (2004) 13-21
2. Lye S.J., OU C.W., Teoh T.G., Erb G., Stevens Y., Casper R., Patel F.-A., and Challis J.R.G. The molecular basis of labour and tocolysis. Fetal Matern. Med. 10 (1998) 121-136
3. Challis J.R., Sloboda D.M., Alfaidy N., Lye S.J., Gibb W., Patel F.A., Whittle L.W., and Newhham J.P. Prostaglandins and mechanisms of preterm birth. Reproduction 124 (2002) 1-17
4. Wickelgren I. Resetting pregnancy's clock. Science 304 (2004) 666-668
5. Rautanen A., Eriksson J.G., Kere J., Andersson S., Osmond C., Tienari P., Sairanen H., Barker D.J.P., Phillips D.I.W., Forsén T., and Kajantie E. Associations of body size at birth with late-life cortisol concentrations and glucose tolerance are modified by haplotypes of the glucocorticoid receptor gene. J. Clin. Endocrinol. Metab. 91 11 (2006) 4544-4551
6. Liko I., Igaz P., Patocs A., Toth S., Pazmany T., Toth M., and Racz K. Sequence variants of the ligand-binding domain of the glucocorticoid receptor gene and their functional consequences on the three-dimensional protein structure. Curr. Med. Chem. 11 (2004) 3229-3237
7. Challis J.R., Sloboda D., Matthews S.G., Holloway A., Alfaidy N., Patel F.A., Whittle W., Fraser M., Moss T.J., and Newhham J. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol. Cell. Endocrinol. 185 1-2 (2001) 135-144
8. Bolt R.J., van Weissenbruch M.M., Popp-Snijders C., Sweep C.C., Lafeber H.N., and Delemarre-van de Waal H.A. Fetal growth and the function of the adrenal cortex in preterm infants. J. Clin. Endocrinol. Metab. 87 (2002) 1194-1199
9. Watterberg K.L., and Scott S.M. Evidence for early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 85 (1995) 120-125
10. Liggins G.C., and Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50 4 (1972) 515-525
11. Elimian A., Figueroa R., Spitzer A.R., Ogburn P.L., Wiencek V., and Quirk J.G. Antenatal corticosteroids: are incomplete courses beneficial?. Obstet. Gynecol. 102 2 (2003) 352-355
12. Panarelli M., Holloway C.D., Fraser R., Connell J.M., Ingram M.C., Anderson N.H., and Kenyon C.J. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab. 83 6 (1998) 1846-1852
13. Rosmond R. The glucocorticoid receptor gene and its association to metabolic syndrome. Obes. Res. 10 10 (2002) 1078-1086
14. Weaver J.U., Hitman G.A., and Kopelman P.G. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J. Mol. Endocrinol. 9 3 (1992) 295-300
15. Buemann B., Vohl M.C., Chagnon M., Chagnon Y.C., Gagnon J., Perusse L., Dionne F., Despres J.P., Tremblay A., Nadeau A., and Bouchard C. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes. Res. 5 3 (1997) 186-192
16. Rosmond R., Chagnon Y.C., Holm G., Chagnon M., Perusse L., Lindell K., Carlsson B., Bouchard C., and Bjorntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes. Res. 8 3 (2000) 211-218
17. Russcher H., Smit P., van den Akker E.L., van Rossum E.F., Brinkmann O.A., de Jong F.H., Lamberts S.W., and Koper J.W. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 90 10 (2005) 5804-5810
18. Huizenga N.A., Koper J.W., De Lange P., Pols H.A., Stolk R.P., Burger H., Grobbee D.E., Brinkmann A.O., De Jong F.H., and Lamberts S.W. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 83 1 (1998) 144-151
19. Luczay A., Torok D., Ferenczi A., Majnik J., Solyom J., and Fekete G. Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency. Eur. J. Endocrinol. 154 (2006) 859-864
20. Dobson M.G., Redfern C.P., Unwin N., and Weaver J.U. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J. Clin. Endocrinol. Metab. 86 5 (2001) 2270-2274
21. Lin R.C., Wang X.L., and Morris B.J. Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41 3 (2003) 404-407
22. Rosmond R. Letter: Glucocorticoid receptor N363S variant in obesity: comes into vanity and goes into darkness. Obes. Res. 11 12 (2003) 1606-1607
23. Roussel R., Reis A.F., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., and Velho G. The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin. Endocrinol. (Oxford) 59 (2003) 237-241
24. Lin R.C., Wang X.L., Dalziel B., Caterson I.D., and Morris B.J. Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11 6 (2003) 802-808
25. van Rossum E.F., Russcher H., and Lamberts S.W. Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene. Trends Endocrinol. Metab. 16 10 (2005) 445-450
26. Derzbach L., Bokodi G., Treszl A., Vasarhelyi B., Nobilis A., and Rigo Jr. J. Selectin polymorphisms and perinatal morbidity in low-birthweight infants. Acta Paediatr. 95 10 (2006) 1213-1217
27. Nobilis A., Szabo M., Kocsis I., Sulyok E., Tulassay T., and Vasarhelyi B. Angiotensin-converting enzyme DD genotype is preventive against circulatory failure in very-low-birthweight neonates. Acta Paediatr. 95 6 (2006) 747-750
28. Treszl A., Kocsis I., Szathmari M., Schuler A., Tulassay T., and Vasarhelyi B. Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr. 90 10 (2001) 1182-1185
29. Lawrence C., Fryer J.G., Karlberg P., Niklasson A., and Ericson A. Modelling of reference values for size at birth. Acta Paediatr. Scand. Suppl. 350 (1989) 55-69
30. Szalai A., Czinner A., and Révai K. The frequency of medium chain acyl CoA dehydrogenase G985 mutation in Hungary. Eur. J. Pediatr. 155 3 (1996) 256
31. Majnik J., Patocs A., Balogh K., Toth M., and Racz K. A rapid and simple method for detection of Asn363Ser polymorphism of the human glucocorticoid receptor gene. J. Steroid Biochem. Mol. Biol. 92 (2004) 465-468
32. Gergics P., Patocs A., Majnik J., Balogh K., Szappanos A., Toth M., and Racz K. Detection of the Bcl I polymorphism of the glucocorticoid receptor gene by single-tube allele-specific polymerase chain reaction. J. Steroid Biochem. Mol. Biol. 100 4-5 (2006) 161-166
33. van Rossum E.F., Koper J.W., Huizenga N.A.T.M., Uitterlinden A.G., Janssen J.A.M.J.L., Brinkmann A.O., Grobbee D.E., de Jong F.H., van Duyn C.M., Pols H.A., and Lamberts S.W. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51 10 (2002) 3128-3134
34. Kajantie E., Phillips D.I., Andersson S., Barker D.J., Dunkel L., Forsen T., Osmond C., Tuominen J., Wood P.J., and Eriksson J. Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism?. Clin. Endocrinol. (Oxford) 57 5 (2002) 635-641
35. E.F. van Rossum, S.W. Lamberts, Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition, Recent Prog. Horm. Res. 59, (2004) 333-357.
36. Tabor B.L., Rider E.D., Ikegami M., Jobe A.H., and Lewis J.F. Dose effects of antenatal corticosteroids for induction of lung maturation in preterm rabbits. Am. J. Obstet. Gynec. 164 (1991) 675-681
37. Wu F.F., Momma K., and Takao A. Cardiovascular and pulmonary effects of betamethasone during midtrimester on fetal rats. Fetal Diagn. Ther. 8 (1993) 89-94
38. Ikegami M., Jobe A.H., Newnham J., Polk D.H., Willet K.E., and Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am. J. Respir. Crit. Care Med. 156 (1997) 178-184
39. Howie R.N., and Liggins G.C. The New Zealand study of antepartum glucocorticoid treatment. In: Farrel P.M. (Ed). Lung Development: Biological and Clinical Perspectives II (1982), Academic Press, New York 255-265
40. Bloom S.L., Sheffield J.S., McIntire D.D., and Leveno K.J. Antenatal dexamethasone and decreased birth weight. Obstet. Gynecol. 97 4 (2001) 485-490
41. Smith G.C.S., Smith M.F.S., McNay M.B., and Fleming J.E.E. First-trimester growth and the risk of low birth weight. N. Engl. J. Med. 339 (1998) 1817-1822